Evolving perspectives on HIV-associated lipodystrophy syndrome: moving from lipodystrophy to non-infectious HIV co-morbidities

Improvements in Subcutaneous Fat, Lipid Profile, and Parameters of Mitochondrial Toxicity in Patients with Peripheral Lipoatrophy When Stavudine is Switched to Tenofovir (LIPOTEST Study)

(2009) Esteban Ribera et al.   HIV CLINICAL TRIALS

Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

(2009) Mari M. Kitahata et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

(2008)   AIDS

Severity of Lipodystrophy Is Associated with Decreased Health-Related Quality of Life

(2008) Giovanni Guaraldi et al.   AIDS PATIENT CARE AND STDS

Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors

(2008) Giovanni Guaraldi et al.   CLINICAL INFECTIOUS DISEASES

Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000–2006

(2008) A Nguyen et al.   HIV MEDICINE

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults

(2008) N Clumeck et al.   HIV MEDICINE

Pathogenesis of cardiovascular disease in HIV infection

(2008) Andrew Carr   Current Opinion in HIV and AIDS

Immune activation and inflammation in HIV-1 infection: causes and consequences

(2007) V Appay et al.   JOURNAL OF PATHOLOGY